about
Human immunodeficiency virus (HIV)-1 integration sites in viral latencyThe intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potencyHIV persistence: chemokines and their signalling pathways.Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy.Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort.Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations.Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitroEx vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.Quantitative Assessment of Intra-Patient Variation in CD4+ T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected SubjectsPreferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes.The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis.HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.HIV integration sites in latently infected cell lines: evidence of ongoing replication.Genetic modulation of TLR8 response following bacterial phagocytosis.The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.Differential dynamics of donor DC and non-DC peripheral blood mononuclear cell microchimerism in lung transplantation.Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.Susceptibility of dendritic cells to HIV-1 infection in vitro.Proximal Versus Distal Splenic Artery Embolisation for Blunt Splenic Trauma: What is the Impact on Splenic Immune Function?Influence of C4 null genes on infection with human immunodeficiency virus.Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report.Immune responses to abacavir in antigen-presenting cells from hypersensitive patients.Salmonella enterica Serovar Typhimurium infection of dendritic cells leads to functionally increased expression of the macrophage-derived chemokine.Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling.Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.Iatrogenic Cushing's syndrome in an HIV-infected patient treated with ritonavir and inhaled fluticasone.Some disease-associated ancestral haplotypes carry a polymorphism of TNF.The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection.Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo.Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infection.Detection and properties of the human proliferative monocyte subpopulation.
P50
Q27026246-5ADAC0DC-A226-4DED-A1D7-8CDADC5F8C4FQ28202197-157AA79C-2B57-49C1-A436-2AD036778211Q33774665-3BDBCC81-B390-427A-A9A4-43CA7B07046AQ33838633-19BFA601-E39E-4768-80AD-84E4D785CA6FQ33854427-DEBFAF34-D6CA-40E5-8572-4277818F49F3Q33916381-0180028A-1D03-4E58-96A2-805997225F69Q33988782-36A99448-3F7E-4D43-ACEE-7DA11A15BCE3Q34165677-3CB71774-9E0B-4F1B-8221-D9694A92B81AQ35006948-D4BD6A43-DAEB-465C-BD17-0DC67C333181Q35054137-5CF17EEA-EC52-4AFE-9171-B59F582035B4Q35436367-A5FFFFD4-1409-4614-BDE4-70DF750BB774Q35674233-96880791-1A9D-424E-89AC-7341FA2E8A23Q35784640-C38592CD-E3DC-41A9-8355-10303688474BQ36053889-764368C8-0C6E-42B6-9DB5-7DB30DE53484Q36068841-4A9CC285-B4BD-4280-A57A-1ADADFF5019BQ36351273-2BEE6FBC-71DC-4FCA-9022-A831C8582FD8Q37129639-32B08E9F-FECE-443D-BB0E-536121EEAFF4Q37586737-A80B0151-D582-4B2D-86E3-C58007ADC390Q39676853-7E109A45-BF06-4E2B-AB86-E3531801706FQ39824443-624579B1-5D20-4227-B8E3-270E5B6A5A43Q39953678-D235FD3D-1A63-4D80-8E48-8547BE576554Q40198241-55132321-F439-4084-BF80-F041E9475A8CQ40217724-AC41C2C9-8FBC-462E-B9FE-70A037C392C3Q40222958-AD95BA0C-94C0-4D0F-B61D-D55B018A2DBCQ40701528-BC3DEEAB-D07B-42A9-905E-178BE6C15187Q40772290-BD7FFAFF-6536-472C-8E7A-E066B5425474Q41389560-C7F36030-A751-47BB-A5C3-B094DC0EB26BQ41808177-B4338F93-D086-4E42-81B6-8CE86B8C9F12Q42513568-92DA7967-C6ED-483E-9E2A-AC78E16180BFQ42704854-E011EE73-E62B-4AAA-97E1-3A44AFE5D4C5Q43041894-F1A84B83-CC06-48D8-B87B-0A9AB00CD9ABQ44370138-03412747-10C5-437A-BC3A-5F1E21E22369Q44664018-70C4967C-7D4A-49C1-9284-17262AA7C6EAQ44712955-8166F303-00B5-48EF-83A4-BB4F07ED9C17Q45081833-38A0663A-F9CD-4165-A131-CB4EF552A30FQ45399784-4AC9D22D-917F-4818-8BEE-0F9AF1CC17D1Q45723296-BB3FFEE3-9A95-4834-8FF8-02F4201CE0A6Q45879191-AE9E7B56-F0D2-46FB-93FE-694B4D0CB41AQ46733268-EE0EDB33-095B-4F3D-BE2D-9A5761A5EA00Q46910160-B6F415EB-ADFC-481E-A123-E90EC602CF4C
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
P U Cameron
@ast
P U Cameron
@en
P U Cameron
@es
P U Cameron
@nl
type
label
P U Cameron
@ast
P U Cameron
@en
P U Cameron
@es
P U Cameron
@nl
prefLabel
P U Cameron
@ast
P U Cameron
@en
P U Cameron
@es
P U Cameron
@nl
P108
P108
P31
P496
0000-0002-1906-6945